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Mycobacterium celatum, a slowly growing potentially pathogenic mycobacterium ﬁrst described in humans, is regarded as an un-
common cause of human infection, though capable of inducing invasive disease in immunocompromised hosts. According to
some reports, a serious disease due to M. celatum may also occur in individuals with no apparent immunodeﬁciency. In animals,
anM.celatum-related diseasehasbeen described inthree casesonly:twice inadomesticferret (Mustelaputorius furo)an do n c ei na
white-tailedtrogon(Trogonviridis).Inthispaper, wereport theﬁrstdetection ofM.celatuminadomesticpig(Susscrofadomestica)
and roe deer (Capreolus capreolus). A nation-wide overview of human M. celatum infections recorded in Slovenia between 2000
and 2010 is also given. Pulmonary disease due to M. celatum was recognized in one patient with a history of a preexisting lung
disease.
1.Introduction
M. celatum, a slowly growing potentially pathogenic myco-
bacterium, was ﬁrst described in humans in 1993 [1]. Its
biochemical characteristics and colony morphology are sim-
ilar to those of M. avium complex, M. xenopi, M. malmoense
and M. shimoidei [1]. Three types of M. celatum have been
identiﬁed on the basis of 16S rDNA sequence heterogeneity
[1, 2], and the possibility of having two diﬀerent 16S rRNA
genes within the genome has been indicated [3]. Diagnostics
of M. celatum can be challenging as the organism can be
misidentiﬁed as M. tuberculosis due to false positive nucleic
acid probe test results [4–6]. Unambiguous identiﬁcation is,
therefore, provided by mycolic acid high-performance liquid
chromatography or nucleic acid sequencing [1, 2].
M. celatum is an uncommon cause of human infection,
but it may induce invasive disease in immunocompromised
hosts. It has been reported to cause infection mainly in
persons aﬀected by AIDS [7–11]. However, a growing list
of reports indicates that a serious disease due to M. celatum
may occur also in non-HIV-infected patients [6, 12–18].
Up to date, only three cases of M. celatum infection have
been reported in animals: two in a domestic ferret (Mustela
putorius furo)[ 19, 20] and one in a white-tailed trogon
(Trogon viridis)[ 21].
In the present work, we report the ﬁrst detection of M.
celatum in a domestic pig (Sus scrofa domestica) and roe deer
(Capreolus capreolus). In addition, anation-wide overviewof
human M. celatum infections recorded in Slovenia between
2000 and 2010 is given.2 Veterinary Medicine International
2.Materialsand Methods
2.1. Animal Isolates. The ﬁrst isolate was obtained in 2000
from a pooled specimen of lymph nodes of pigs (n = 30).
Granulomatous changes on the submandibular lymph nodes
were visible during routine tuberculosis monitoring at
slaughterhouse. The second isolate was obtained in 2010
fromaroedeerinthescopeofastudyontuberculosisinwild
animals. No gross lesions characteristic of tuberculosis were
observed on the specimens collected from roe deer (Table 1).
2.2. Human Isolates. A total of 21 M. celatum isolates from
seven patients (two males, ﬁve females) were recorded in
Slovenia in the period from 2000 to 2010. HIV status of the
aﬀected persons was unknown except for one patient who
was conﬁrmed to be HIV-negative (Table 2(b)). According
to the low prevalence of AIDS (<0.1% in 2009) [23]i n
Slovenia and the age of the patients, HIV infection was
regarded as unlikely for the majority of them. All the isolates
were collected and identiﬁed at the National Reference
Laboratory for Mycobacteria of the University Clinic Golnik
in the scope of routine diagnostics of TB and diseases
caused by nontuberculous mycobacteria in humans. With
the exception of one, all the isolates were cultured from
sputum specimens. An overview of the human isolates
included in this study is shown in Table 2(b).
2.3. Histopathology. Specimen of pig lymph nodes was sub-
jectedtoZiehl-Neelsen(ZN)andhematoxylin-eosin staining
for the histopathological examination.
2.4. Bacteriology and Identiﬁcation (Animal Isolates). Speci-
men smears were ZN stained and examined microscopically
for the presence of acid-fast bacilli (AFB). Specimens of
animal tissues were processed according to the protocol
described by Kent and Kubica [24] and inoculated onto
the following selective media: L¨ owenstein-Jensen (one slant
supplemented with pyruvate and one slant supplemented
with glycerin), Stonebrink, Middlebrook 7H10 and BBL
MGIT (Mycobacteria Growth Indicator Tube, Becton Dick-
inson, USA). Smears of the grown bacteria were ZN stained
to conﬁrm that they comprised AFB. Identiﬁcation of the
isolates was based on a combination of phenotypic char-
acteristics and molecular methods. Growth rate, growth
at diﬀerent temperatures, and colony morphology were
recorded. According to the phenotypic features, the isolates
were subjected to PCR ampliﬁcation targeting the insertion
sequences characteristic of M. avium.D N Ae x t r a c t e df r o m
theselected colonieswas subjectedto IS1245and FR300 PCR
ampliﬁcation employing primersets and protocolsdescribed
previously [25, 26]. In addition, a hybridization assay using
GenoType Mycobacterium CM and AS culture identiﬁcation
kits (Hain Lifescience, Germany) was performed according
to the manufacturer’s instructions. The pig isolate was sub-
jected to 16S rDNA sequencing at the National Reference
Center for Mycobacteria of the Research Center Borstel in
Germany. To determine the phylogenetic aﬃliation of the
roe deer isolate, PCR using mycobacteria-speciﬁc primer
pair 285/264 targeting 16S rRNA gene [27] was performed.
Ribosomal PCR amplicons were puriﬁed from agarose gels
after the electrophoretic separation using PureLink Quick
Gel Extraction Kit (Invitrogen, USA) following the manu-
facturer’s instructions and were sequencedinbothdirections
(Macrogen, Korea). The retrieved sequence fragments were
submittedto megablast classiﬁcation accessed through NCBI
website (http://www.ncbi.nlm.nih.gov/).
2.5. Bacteriology and Identiﬁcation (Human Isolates). Spec-
i m e n sf r o mh u m a n sw e r ea u r a m ine stained and examined
by ﬂuorescent microscope for AFB. All specimens were pro-
cessed according to the protocol described by Vestal [28]a n d
inoculated onto two solid media (L¨ owenstein-Jensen and
Stonebrink) and into BACTEC MGIT 960 liquid medium
(BectonDickinson, USA).The following phenotypiccharac-
teristics were investigated: growth rate, growth at diﬀerent
temperatures, microscopic examination of colony morpho-
logyonMiddlebrook7H10agarplates,andbiochemicalacti-
vity. Biochemical testsperformed are summarized in Table 3.
Identiﬁcation with the GenoType Mycobacterium CM and
AS culture identiﬁcation kits (Hain Lifescience, Germany)
was also performed, following the manufacturer’s instruc-
tions. Details on the identiﬁcation tests used in human iso-
l a t e sa r eg i v e ni nT a b l e2(b).
3.Results
3.1. Pig Isolate. Bacterial growth appeared on three of the
ﬁve inoculated media (Table 1). Growth was ﬁrst detected
after 19 days in liquid medium; nine days later, smooth
ﬁlamentous (Figure 1) yellow pigmented colonies appeared
on solid medium. PCR tests for M. avium gave negative
results. Initially, the isolate was identiﬁed as a member of
the genus Mycobacterium as diagnostic tests employed in
our laboratory at the time of investigation did not enable
identiﬁcation of various nontuberculous mycobacteria to
the species level. In 2003, GenoType Mycobacterium culture
identiﬁcation kit was introduced into laboratory routine
work as a tool for improved identiﬁcation of mycobacteria.
As a result of retrospective investigation, the pig isolate was
identiﬁed as M. celatum and was sent to the National Refer-
ence Centerfor Mycobacteria of the Research CenterBorstel,
Germany, for DNA sequencing which conﬁrmed the isolate’s
identity (data on type were not available). Histopathological
examination of the pig lymph node specimen revealed ZN
negative partially incalcinated incapsulated granulomas.
3.2. Roe Deer Isolate. Bacterial growth occurred after 34 days
on three media inoculated with the lymph node material.
PCR tests for M. avium were negative. Using GenoType
Mycobacterium CM and AS culture identiﬁcation kits and
DNA sequencing, the isolate was identiﬁed as M. celatum.
Sequencingshowed a duplicationofelectropherogram peaks
after the reported insertion of additional T in position
214 [3]. Clear sequencing patterns were obtained after
manual correction that revealed the presence of two diﬀerentVeterinary Medicine International 3
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Table 2
(a) An overview of laboratory diagnostics of mycobacteria in humans in Slovenia between 2000 and 2010
Year No. of specimens M. tuberculosis M. bovis M. caprae M. bovis BCG NTMa M. celatum
2000 17016 1022 0 0 0 180 0
2001 17576 1298 0 1 0 182 0
2002 16062 1178 0 0 2 170 2
2003 15236 1132 0 0 1 213 2
2004 12268 972 0 0 3 136 0
2005 11556 923 0 0 0 211 1
2006 11753 852 0 1 2 207 2
2007 11995 874 0 2 0 182 2
2008 11566 889 0 0 0 178 5
2009 11855 817 0 0 1 299 2
2010b 12118 nac nac nac nac nac 5
Total
b 149001 nac nac nac nac nac 21
aNontuberculous mycobacteria.
bLaboratory diagnosticsof specimens received in 2010 are still ongoing; as the ﬁnal reports are not yet available at the time of writing, only the numbero f
investigated specimens is given.
cNot available yet.
(b) Details on diagnostics of M. celatum from humans
Patient Gender Year of birth No. of
isolates
Year of
isolation1 Sample Microscopy2 Growth on
media Identiﬁcation Treatment
A Female 1912 1 2002 Sputum −3 LJ6 CM10,B C 11,
GT12 No
B Female 1947 1 2002 Sputum − MGIT7 CM, BC, GT No
C∗ Female 1929 2 2003 Sputum − MGIT CM, BC, GT No
D Male 1959 1 2005 Sputum − MGIT CM, BC, GT No
C∗ Female 1929 2 2006 Sputum − MGIT CM, GT No
C∗ Female 1929 2 2007 Sputum ±4 LJ, ST8,
MGIT CM, GT No
C∗ Female 1929 5 2008 Sputum ±5 LJ, ST, MGIT CM, GT Yes
E Female 1932 1 2009 Bronchial
aspirate
− Baniˇ cl i q u i d
medium9 CM, GT No
F Male 1971 1 2009 Sputum − LJ, MGIT CM, GT No
C∗ Female 1929 4 2010 Sputum − LJ, ST, MGIT CM, GT Yes
G Female 1974 1 2010 Sputum − MGIT CM, GT No
∗Patient with M. celatum pulmonary disease and a history of tuberculosis and M. avium and M. intracellulare-related pulmonary mycobacteriosis;
conﬁrmed as HIV-negative.
1No M. celatum isolates were identiﬁed in years 2000, 2001, and 2004.
2Auramin ﬂuorescent staining.
3Negative.
4One specimen positive and one specimen negative for acid-fast bacilli.
5Four specimens positive and one specimen negative for acid-fast bacilli.
6L¨ owenstein-Jensen medium.
7Mycobacteria Growth Indicator Tube (Becton Dickinson, USA), liquid medium.
8Stonebrink medium.
9In-house liquid medium containing human serum (described in [22]).
10Colony morphology.
11Biochemical tests (for details, see Table 3).
12GenoType Mycobacterium CM and AS culture identiﬁcation kits(Hain Lifescience,Germany).
16S rRNA gene copies (i.e., type 1 and type 3) in the genome
of M. celatum (Table 1).
3.3. Human Isolates. Auramine staining generated positive
results in ﬁve out of 21 specimens from which M. celatum
was later cultivated. All smear positive specimens belonged
to one patient with pulmonary disease due to M. celatum.
The vast majority of isolates grew in liquid medium; in eight
out of 21 cases, the liquid medium was the only medium in
which bacterial growth was detected. Colonies that appearedVeterinary Medicine International 5
Table 3: Results of biochemical tests performed on human M.
celatum isolates collected between 2002 and 20051.
Test Result
Semiquantitative catalase 37◦C <45mm of foam
Catalase 68◦C+
Tween hydrolysis (5 days/10 days) −/−
Arylsulfatase (3 days/14 days) +/+
Tellurite reduction +
Iron uptake −
Tolerance to 5% NaCl −
Tolerance to TCH2 (10µg/mL) +
Growth on MacConkey agar −
Growth at 25◦C+
Growth at 30◦C+
Growth at 37◦C+
Growth at 45◦C −
Growth rate Slow
Colony morphology (Middlebrook 7H10 agar) Smooth
1From the beginning of 2006, identiﬁcation of the isolates did not include
biochemical tests any more. Five M. celatum isolates from the period
2002–2005, on which biochemical tests were performed, displayed uniform
biochemicalcharacteristicsshown in this table.
2TCH: thiophene 2-carboxylic hydrazide.
Figure 1: Colony morphology of pig M. celatum isolate grown on
Middlebrook 7H10 agar plates and viewed under the microscope
(×100).
on solid media were small and smooth. Until the end of
2003, the identiﬁcation was based on phenotypic methods
(colony morphology under stereomicroscope, biochemical
tests).However,theywere not discriminative enoughand the
isolates were identiﬁed as nonchromogenic mycobacteria.
Biochemical features of the investigated isolates are shown in
Table 3andareconsistentwiththecharacteristicslistedinthe
ﬁrst descriptionofthespecies[1].GenoTypeMycobacterium
CM and AS culture identiﬁcation kits were introduced into
routine work in 2004 and have been used since for the
identiﬁcation of all investigated mycobacterial isolates to
the species level. The isolates of unknown mycobacterial
species cultured between 2000 and 2003 were identiﬁed in
retrospective. The results of bacteriological and molecular
investigations of the human isolates are summarized in
Table 2(b).
4.Discussion
In the ﬁrst reports on M. celatum in animals, the organism
was identiﬁed as the aetiological agent of disseminated gran-
ulomatous infections. The ﬁndings related to the infection
ranged from classical tuberculous lesions with well-deﬁned
granulomas in the white-tailed trogon [21] to poorly deﬁned
granulomas described in the ferret [19]. The lesions present
in the trogon were identical as those seen in classical avian
mycobacteriosis caused by M. avium [21]. The route of
infection was not determined although the lesions in the
respiratory tract indicated transmission by inhalation [19,
21]. The source of infection was also unknown; however,
as most mycobacteria are ubiquitous environmental sapro-
phytes [29], exposure to soil or water seems to be the
most probable source. The presence of M. celatum in the
environment has been demonstrated by its isolation from
a bioﬁlm in an aquarium [30] and by the detection of
M. celatum-like DNA sequence from the soil [31]. The
last paper on M. celatum infection in animals concerns
splenitis in a ferret. Common occurrence of M. celatum
in ferrets could be explained by the supposition that they
are more susceptible to mycobacterial infections as many
mycobacteria, for example, M. bovis, M. microti, M. avium,
M. triplex, M. fortuitum, M. ﬂorentinum, M. interjectum,a n d
M. intracellulare, have been isolated from this animal species
[32–34].
In the animal specimens investigated in this study, no
AFB were detected by ZN staining of the tissue smears.
Previous papers on M. celatum infection in animals report
positive smear microscopy, but low numbers of AFB were
recorded in some instances [20, 21]. The growth times of
the bacteria from pig and roe deer were in between the
growth times reported previously. Bacterial growth from the
pig lymph node specimen was ﬁrst detected after 19 days
of incubation in liquid medium. Smooth ﬁlamentous and
yellow pigmented colonies appeared after 28 days on one of
the solid media. Bacterial growth from the roe deer lymph
nodespecimenwasdetectedinliquidandontwosolidmedia
after 34 days. For comparison, in a ferret with disseminated
M. celatum infection, yellow colonies were visible after ten
days [19] while small smooth and pale colonies from the
ferret with splenitis appeared after eight weeks [20]. M.
celatum types revealed in animals comprise type 1 in the
trogon[21] andtype3in theferret withdisseminated disease
[19] while the type identiﬁed in the ferret with splenitis
demonstrated close relatedness to the human M. celatum
strains types1and3[20].Ourisolatefromroedeerharbored
two diﬀerent 16S rRNA gene copies, that is, of types 1 and 3.
The signiﬁcance of M. celatum infection in the animals
described in this paper is unclear. The presence and the
location of TB-like lesions indicate that M. celatum is
a potentially pathogenic organism for pigs which might6 Veterinary Medicine International
get infected per os. The granulomatous changes resembled
those seen in pigs infected with M. bovis or M. avium.
Therefore, M. celatum infection might be important from
the standpoint of making correct diagnosis. In roe deer
specimens, there were no gross pathological changes seen
on liverand thelymph nodes; histopathologicalexamination
was not performed. The ﬁnding of M. celatum in the lymph
node tissue could be a result of ubiquitous nature of the
organism, which is likely to be widespread in the environ-
ment. In both animal species, the isolation of M. celatum
was a rare event. Among 152 mycobacteria isolated from
pigs between 2000 and 2010, the majority (92.1%) belonged
to M. avium. A few isolates of Mycobacterium sp., M. terrae
and M. fortuitum were also detected. M. celatum represented
0.67% of isolates. A more detailed overview of mycobacteria
in animals in Slovenia was published recently [35]. The
mycobacteria detection rate in wild animals was lower. The
national study on tuberculosis in wild animals started in
2010. During this year, a total of 108 animals of various
species were sampled and eight isolates of nontuberculous
mycobacteria were detected. Two out of 31 roe deer were
positive for mycobacteria; one isolate was identiﬁed as M.
celatum and another as Mycobacterium sp.
M. celatum has been mainly recognized as the causative
agentofpulmonaryanddisseminated infectionsinimmuno-
compromised humans [16]. It may aﬀect also immunocom-
petent patients [6, 12, 16]; however, some authors discussed
the possibility that the host’s defense failure associated with
M. celatum infection suggests a possible hidden immunod-
eﬁciency rather than a true immunocompetence [14]. The
review of the literature concerning M. celatum infection in
non-HIV-infected patients revealed eight reports from seven
countries in the past 16 years [6, 12–18]. Among nine cases
of human M. celatum infection, three patients had a history
of pulmonary TB [14, 17, 18], one of TB lymphadenitis and
chronic obstructive pulmonary disease [15], one of diabetes
mellitus [13], and one was a lung transplant recipient [16]
while for three patients no underlying disease was recorded
[6, 12, 16]. In all patients, M. celatum caused pulmonary
infection with the exception of two lymphadenitis cases
in children [12, 16]. Outcome of antibiotic treatment was
favorableforﬁveoutofsevenadultpatientswhile inchildren
a surgery (in one case supported by antibiotic treatment)
resulted in regression of illness [17]. Smear microscopy was
mostly positive for AFB. The methods used for the identi-
ﬁcation of the isolates involved phenotypic and molecular
methods; deﬁnitive diagnosis was provided by 16S rDNA
sequencing in the majority of cases.
During an eleven-year period, a total of 21 M. celatum
isolates belonging to seven patients were discovered among
149,000 specimens from humans investigated in Slovenia
(Table 2(a)). M. celatum represented about 0.82% of isolates
of nontuberculous mycobacteria identiﬁed between 2000
and 2010. With the exception of one isolate from bronchial
aspirate, M. celatum isolates were cultivated from sputum.
Smear microscopy (ﬂuorescent auramine staining) was pos-
itive only in ﬁve sputa from one patient with pulmonary M.
celatum disease. The remaining specimens were negative for
AFB.
The occurrence of M. celatum in ﬁve patients, in which
singlesputumspecimenswereinvestigated,maybeexplained
b yt h ep r e s e n c eo ft h i so r g a n i s mi nt h ee n v i r o n m e n t .T h e
ﬁnding of these isolates could be regarded as random
with no particular signiﬁcance. In one patient, M. celatum
was isolated from bronchial aspirate. Since bronchi are
considered asa usually sterile site, theisolation ofM.celatum
from such a site could indicate the clinical importance
of the infection. However, no further specimens of this
77-year-old patient were investigated. In order to meet
the criteria for diagnosis of nontuberculous mycobacteria
pulmonary disease, published by American Thoracic Society
[36], several specimens should be collected within one year
and evaluation of clinical and radiographic ﬁndings should
be performed along with the results of bacteriology.
Therefore, among M. celatum isolates recovered from
humans in Slovenia up to date, M. celatum infection was
of clinical signiﬁcance only in one elderly patient (born in
1929) with a history of tuberculosis (1952–1954, treated by
thoracoplasty). In 2002–2003 and 2005–2006, this patient
was treated also for M. avium-related and M. intracellulare-
related pulmonary disease, respectively. The repeated iso-
lation of M. celatum from 15 sputum specimens (among
them, ﬁve smear positive) in ﬁve years conﬁrms the clinical
importance of the infection in this patient. The patient was
ﬁrst subjected to antibiotic therapy at the end of 2008. The
outcome of the therapy is unknown as no specimens were
received after the beginning of treatment course. However,
the four M. celatum isolates obtained in 2010 and repeated
therapy suggest recurrence of pulmonary infection. This
case demonstrates that a preexisting lung disease represents
an important risk factor for M. celatum pulmonary infec-
tion. This can be concluded also from the cases reported
previously as the description of underlying diseases in M.
celatum-infected patients often involved lung diseases, most
frequently TB [17].
In conclusion, the ﬁnding of M. celatum in animals and
humans suggests its presence in the environment. Its ability
to induce TB-like lesions in pig indicates that the organism
is potentially pathogenic for this animal species. In addition,
M. celatum was recognized as the etiological agent of pul-
monary infection in a patient with a history of a preexisting
lung disease.
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